Broker research reports for stocks which have been downgraded by brokers. Both recommendation downgrades,
as well as share price target downgrades are available .
Broker Research reports: latest Downgrades
for all stocks
INDIA l Institutional Research l Chemicals l 01st November 2021 Valiant Organics l BUY l TP: 1,975 Robust revenue growth, margins play spoilt sport We maintain a BUY rating with a revised TP of Rs1,975 (earlier Rs2,100); revision is largely on account of increase in RMAT costs, which has led to downgrade in earnings for FY22E/FY23E. The company posted impressive revenue growth of 64% YoY and 12% QoQ driven by improved realisation rates and increasing utilisation of enhanced capacities; we believe that this strong revenue growth should sustain. However, high RMAT and freight...
Hence we maintain our HOLD rating on the stock. We value the company at 19x of its FY23E EV/EBITDA to arrive at a target price of Rs 30,000/share, implying an upside of 5% from CMP.
With the increasing profitability & reduction in sugar inventories, DBS would be generating cumulative free cash flow of | 626 crore in the next three years despite ~| 700 crore capex...
We value KEC International at 14x FY23E EPS to arrive at a target price of Rs465/share, implying a downside of 3% from CMP. Given a long-term positive outlook, we maintain a HOLD rating on the stock..
